Free Trial

FY2024 Earnings Estimate for SunOpta Issued By William Blair

SunOpta logo with Consumer Staples background

SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY - Equities researchers at William Blair dropped their FY2024 earnings estimates for SunOpta in a note issued to investors on Tuesday, November 5th. William Blair analyst J. Andersen now anticipates that the company will post earnings per share of $0.11 for the year, down from their prior estimate of $0.12. The consensus estimate for SunOpta's current full-year earnings is $0.14 per share.

A number of other equities analysts have also recently commented on the stock. Stephens lifted their target price on shares of SunOpta from $9.00 to $10.00 and gave the company an "overweight" rating in a report on Wednesday. DA Davidson reaffirmed a "buy" rating and issued a $9.00 target price on shares of SunOpta in a report on Thursday, October 10th. Finally, StockNews.com cut shares of SunOpta from a "hold" rating to a "sell" rating in a report on Friday, November 1st. One research analyst has rated the stock with a sell rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, SunOpta currently has a consensus rating of "Moderate Buy" and a consensus target price of $9.50.

Check Out Our Latest Research Report on SunOpta

SunOpta Stock Performance

Shares of SunOpta stock traded down $0.16 during trading on Friday, reaching $7.29. The company's stock had a trading volume of 674,472 shares, compared to its average volume of 811,304. The company has a 50-day moving average price of $6.30 and a two-hundred day moving average price of $5.89. The firm has a market cap of $870.79 million, a PE ratio of -40.55 and a beta of 1.83. SunOpta has a fifty-two week low of $3.85 and a fifty-two week high of $7.59. The company has a current ratio of 1.20, a quick ratio of 0.61 and a debt-to-equity ratio of 1.61.

SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last announced its earnings results on Tuesday, November 5th. The company reported $0.02 EPS for the quarter, meeting analysts' consensus estimates of $0.02. The business had revenue of $176.22 million for the quarter, compared to analysts' expectations of $172.30 million. SunOpta had a negative net margin of 2.74% and a positive return on equity of 7.92%.

Hedge Funds Weigh In On SunOpta

A number of hedge funds and other institutional investors have recently bought and sold shares of STKL. BNP Paribas Financial Markets grew its position in SunOpta by 86.6% in the 1st quarter. BNP Paribas Financial Markets now owns 77,955 shares of the company's stock valued at $536,000 after buying an additional 36,172 shares during the last quarter. Heartland Advisors Inc. boosted its position in shares of SunOpta by 11.1% during the 1st quarter. Heartland Advisors Inc. now owns 500,000 shares of the company's stock worth $3,435,000 after purchasing an additional 50,000 shares in the last quarter. Tectonic Advisors LLC boosted its position in shares of SunOpta by 13.6% during the 1st quarter. Tectonic Advisors LLC now owns 233,824 shares of the company's stock worth $1,606,000 after purchasing an additional 27,908 shares in the last quarter. Quantum Private Wealth LLC boosted its position in shares of SunOpta by 17.6% during the 1st quarter. Quantum Private Wealth LLC now owns 66,673 shares of the company's stock worth $458,000 after purchasing an additional 10,000 shares in the last quarter. Finally, HBK Sorce Advisory LLC purchased a new stake in shares of SunOpta during the 1st quarter worth $211,000. 85.39% of the stock is currently owned by hedge funds and other institutional investors.

About SunOpta

(Get Free Report)

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.

Further Reading

→ My #1 Pre IPO Trade for 2025 – NAME and TICKER (From Wyatt Investment Research) (Ad)

Should you invest $1,000 in SunOpta right now?

Before you consider SunOpta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.

While SunOpta currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines